SHR0302 ointment
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SHR0302 ointment, covering 2022-07-13 to 2023-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis [Phase 2, Phase 3]